Clinical Trial Update: A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis. [Phase 2]

View source ↗

Summary

Phase 2 trial PF-07038124 in patients with Atopic dermatitis and Plaque psoriasis has completed, with results posted on 2024-10-02.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Plaque Psoriasis

Drugs mentioned

• PF-07038124

Snippet

Sponsor: Pfizer | Conditions: Atopic Dermatitis, Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2024-10-02